SCHEMBL3402575

SCHEMBL3402575

CC(C)(C=O)Cc1c[nH]c2ncc(-c3ccc(C(=O)N4CCC(C)(O)CC4)s3)nc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VNN1 O95497 1/20 0.34
HTR1A P08908 5/20 0.33
NPC1 O15118 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
RAB9A P51151 3/20 0.33
KDM4E B2RXH2 2/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
PKLR P30613 1/20 0.32
ERN1 O75460 1/20 0.31
PKM P14618 1/20 0.31
JAK3 P52333 1/20 0.30
ADORA2A P29274 1/20 0.30
ADORA1 P30542 1/20 0.30
CCNK O75909 1/20 0.30
CCNE1 P24864 1/20 0.30
CDK2 P24941 1/20 0.30
CDK12 Q9NYV4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3400234 0.91 YEATS4 (0.39) NPC1ALDH1A1MAPTRAB9AKDM4E
SCHEMBL3402586 0.91 YEATS4 (0.36) NPC1ALDH1A1MAPTRAB9AKDM4E
SCHEMBL3401648 0.90 YEATS4 (0.38) NPC1ALDH1A1MAPTRAB9AKDM4E
SCHEMBL1892784 0.82 JAK3 (0.41) PKLRJAK3
SCHEMBL14795160 0.81 SYK (0.37) VNN1NPC1ALDH1A1MAPTRAB9A
SCHEMBL1368921 0.78 JAK3 (0.51) JAK3
SCHEMBL1893368 0.77 JAK3 (0.38) JAK3
SCHEMBL3391851 0.77 MAPK1 (0.37) HTR1ASMN1; SMN2JAK3
SCHEMBL3401584 0.76 MAPK1 (0.36) NPC1ALDH1A1RAB9ASMN1; SMN2PKM
SCHEMBL3401563 0.76 HPGD (0.38) NPC1ALDH1A1RAB9APKMJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2247592-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-11-10 EP disclosed
WO-2009106442-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-09-03 WO disclosed